Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056988 · ClinicalTrials.gov registry record · Phase 4
tSCI Contrast Enhanced Ultrasound Study
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 27
- Enrollment target
NCT04056988 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 27 participants.
The verdict
NCT04056988, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 27 participants
- Enrollment target
Study Summary
Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on the spinal cord tissue and decreased spinal cord blood flow at the site of injury. The combination of increased pressure and decreased blood flow causes vascular hypo-perfusion of the spinal cord and exacerbates the severity of the injury. This is also referred to as secondary injury. Thus, knowledge of spinal cord hypo-perfusion would allow the treating physician to optimize the hemodynamic condition of patients with acute spinal cord injury and potentially improve functional outcomes. The investigators plan to use contrast-enhanced ultrasound (CEUS) to determine the decrease of blood flow in the spinal cord at the site of injury, during the routine surgery that these patients require to decompress and stabilize their injured spine. This may help the investigators to determine the efficacy of certain treatments in improving blood flow and patients suffering from tSCI.
Interventions
- DRUG Perflutren Lipid Microsphere
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2023-11-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056988
The ClinicalTrials.gov registry entry for NCT04056988 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perflutren Lipid Microsphere is the first listed.
NCT04056988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04056988 about?
NCT04056988 is a clinical study titled "tSCI Contrast Enhanced Ultrasound Study". Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on the spinal cord tissue and decreased spinal cord blood flow at the site of injury. The combination of...
What is the current status of trial NCT04056988?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2018-07-31. Estimated completion is 2023-11-20.
What interventions are being tested in trial NCT04056988?
The interventions under investigation include: Perflutren Lipid Microsphere (DRUG).
Who is sponsoring clinical trial NCT04056988?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.